High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
Saved in:
| Title: | High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland. |
|---|---|
| Authors: | Pathmanathan I; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Epidemic Intelligence Service, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Pasipamire M; Swaziland National AIDS Programme, Ministry of Health, Mbabane, Swaziland., Pals S; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Dokubo EK; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Preko P; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Ezulwini, Swaziland., Ao T; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Ezulwini, Swaziland., Mazibuko S; Swaziland National AIDS Programme, Ministry of Health, Mbabane, Swaziland., Ongole J; University Research Co., LLC, Mbabane, Swaziland., Dhlamini T; Swaziland National TB Control Program, Ministry of Health, Manzini, Swaziland., Haumba S; University Research Co., LLC, Mbabane, Swaziland. |
| Source: | PloS one [PLoS One] 2018 May 16; Vol. 13 (5), pp. e0196831. Date of Electronic Publication: 2018 May 16 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
